Rosacea is a chronic skin disease characterized by damages on the small blood vessels of the face. It is considered as the reason number 6 for a dermatologist’s consultation. Demodex and the impaired function of skin microbiome are known as rosacea’s key actors, inducing a vicious circle of inflammation behind the disease. However, sphingobioma offers a promising solution for rosacea patients by breaking the inflammation cycle at different stages.

ROSACEA, A COMMON YET IMPACTFUL DISEASE FOR THOSE AFFECTED

ROSACEA FEATURES FLUSHING, AND PERSISTENT ERYTHEMA AT THE CENTER OF THE FACE, WITH A MASSIVE IMPACT ON THE PSYCHO-SOCIAL STATE AND QUALITY OF LIFE OF PATIENTS.

ROSACEA’S MAIN AND DIFFERENT CLINICAL SIGNS

THE INFLAMMATION VICIOUS CIRCLE INDUCED BY ROSACEA’S KEY ACTORS

SPHINGOBIOMA, A UNIQUE AND PROMISING BACTERIAL STRAIN FOR ROSACEA TREATMENT

SPHINGOBIOMA ACTS ON SKIN MICROBIOME FUNCTION AND DEMODEX INDUCED INFLAMMATION.

THE CLINICAL PROVEN EFFICACY OF SPHINGOBIOMA MAKES IT A PROMISING SOLUTION FOR ROSACEA PATIENTS, HELPING IN THE IMPROVEMENT OF THEIR CLINICAL SIGNS, THUS POSITIVELY IMPACTING THEIR QUALITY OF LIFE.